234 related articles for article (PubMed ID: 33531521)
1. An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer.
Thambiraj S; Vijayalakshmi R; Ravi Shankaran D
Sci Rep; 2021 Feb; 11(1):2808. PubMed ID: 33531521
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cytotoxic activity of docetaxel loaded gold nanoparticles for lung cancer drug delivery.
Thambiraj S; Shruthi S; Vijayalakshmi R; Ravi Shankaran D
Cancer Treat Res Commun; 2019; 21():100157. PubMed ID: 31310876
[TBL] [Abstract][Full Text] [Related]
3. Plasmonic photothermal release of docetaxel by gold nanoparticles incorporated onto halloysite nanotubes with conjugated 2D8-E3 antibodies for selective cancer therapy.
Taheri-Ledari R; Zhang W; Radmanesh M; Cathcart N; Maleki A; Kitaev V
J Nanobiotechnology; 2021 Aug; 19(1):239. PubMed ID: 34380469
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.
de Oliveira R; Zhao P; Li N; de Santa Maria LC; Vergnaud J; Ruiz J; Astruc D; Barratt G
Int J Pharm; 2013 Oct; 454(2):703-11. PubMed ID: 23701998
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
[TBL] [Abstract][Full Text] [Related]
6. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
[TBL] [Abstract][Full Text] [Related]
7. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
Shitole AA; Sharma N; Giram P; Khandwekar A; Baruah M; Garnaik B; Koratkar S
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111035. PubMed ID: 32994029
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of self-assembly Soluplus
Jiang S; Mou Y; He H; Yang D; Qin L; Zhang F; Zhang P
Drug Dev Ind Pharm; 2019 Nov; 45(11):1788-1798. PubMed ID: 31500443
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of PEGylated nanographene oxide as a nanocarrier for docetaxel drugs and anticancer activity on prostate cancer cell lines.
Tas A; Keklikcioglu Cakmak N
Hum Exp Toxicol; 2021 Jan; 40(1):172-182. PubMed ID: 32909849
[TBL] [Abstract][Full Text] [Related]
11. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
13. Orthogonal analysis of functional gold nanoparticles for biomedical applications.
Tsai DH; Lu YF; DelRio FW; Cho TJ; Guha S; Zachariah MR; Zhang F; Allen A; Hackley VA
Anal Bioanal Chem; 2015 Nov; 407(28):8411-22. PubMed ID: 26362156
[TBL] [Abstract][Full Text] [Related]
14. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel gold complex nanoflowers: A chemo-biological evaluation for their use as nanotherapeutics.
Haddada MB; Movia D; Prina-Mello A; Spadavecchia J
Colloids Surf B Biointerfaces; 2020 Oct; 194():111172. PubMed ID: 32534368
[TBL] [Abstract][Full Text] [Related]
16. Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer.
Minassian G; Ghanem E; Hage RE; Rahme K
Nanotheranostics; 2023; 7(2):152-166. PubMed ID: 36793347
[TBL] [Abstract][Full Text] [Related]
17. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
18. Green synthesis of multifunctional PEG-carboxylate π back-bonded gold nanoconjugates for breast cancer treatment.
Gajendiran M; Jo H; Kim K; Balasubramanian S
Int J Nanomedicine; 2019; 14():819-834. PubMed ID: 30774336
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
Chen Y; Xu Z; Lu T; Luo J; Xue H
Drug Deliv; 2022 Dec; 29(1):2705-2712. PubMed ID: 35980107
[TBL] [Abstract][Full Text] [Related]
20. Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
Saniee F; Shabani Ravari N; Goodarzi N; Amini M; Atyabi F; Saeedian Moghadam E; Dinarvand R
Pharm Dev Technol; 2021 Apr; 26(4):381-389. PubMed ID: 33538232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
